Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products. Elixinol Global’s businesses include:
Elixinol USA, which was founded in 2014, is a manufacturer and global distributor of industrial hemp-based dietary supplement and skin care products, with operations based out of Colorado, USA.
Hemp Foods Australia, which was founded in 1999, is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products, with operations based out of Bangalow, Australia.
Nunyara was founded in 2014 to participate in the emerging Australian medicinal cannabis market. The Company submitted license applications for cultivation and manufacture to the Office of Drug Control in early 2018. Nunyara was granted a licence to manufacture medical cannabis in July 2019, and the cultivation licence is pending approval so there are no current operations.
To view the Notification of issue, conversion or payment up of equity +securities, download the attached PDF.
In accordance with Listing Rule 12.10, Elixinol Global Limited (Elixinol Global or the Company) (ASX:EXL; OTC:ELLXF) provides its revised Securities Trading Policy (Policy), which was approved by th…